Trial Profile

A Randomized, Double-blind Study Comparing the Effect of Different Treatment Regimens of Intravenous Bonviva on Lumbar Bone Mineral Density in Women With Osteoporosis

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 09 Nov 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Ibandronic acid (Primary) ; Ibandronic acid
Indications Postmenopausal osteoporosis
Focus Pharmacodynamics
Acronyms DIVA
Sponsors Roche

Most Recent Events

21 Jul 2011 Actual end date of the extension trial is Nov 2008 as reported by ClinicalTrials.gov (NCT00551174).
21 Jul 2011 Status of the extension trial is completed as reported by ClinicalTrials.gov (NCT00551174).
21 Jul 2011 Actual initiation date (Oct 2004) added as reported by ClinicalTrials.gov (extension trial; NCT00551174).

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com